Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes

Ann Intern Med. 2012 Jan 17;156(2):JC1-7. doi: 10.7326/0003-4819-156-2-201201170-02007.
No abstract available

Publication types

  • Comment